Related content

Human pharmacokinetic profiling of the dipeptidyl peptidase‐IV inhibitor teneligliptin using physiologically based pharmacokinetic modeling

By  

Biopharmaceutics And Drug Disposition, Vol. 36, Iss. 3, 2015-04 ,pp. : 148-162

John Wiley & Sons Inc

Access to resources Recommend Favorite

Physiologically Based Pharmacokinetic (PBPK) Modeling of Caffeine and Theophylline in Neonates and Adults: Implications for Assessing Children's Risks from Environmental Agents

By Ginsberg Gary   Hattis Dale   Russ Abel   Sonawane Babasaheb  

Journal of Toxicology and Environmental Health, Vol. 67, Iss. 4, 2004-06 ,pp. : 297-329

Taylor & Francis Ltd

Access to resources Recommend Favorite

Quantitative low-dose assessment of seafood toxin, domoic acid, in the rat brain: application of physiologically-based pharmacokinetic (PBPK) modeling

By Kim C.S.   Ross I.A.   Sandberg J.A.   Preston E.  

Environmental Toxicology and Pharmacology, Vol. 6, Iss. 1, 1998-08 ,pp. : 49-58

Elsevier

Access to resources Recommend Favorite

Impact of Physiologically Based Pharmacokinetic Modeling on Benchmark Dose Calculations for TCDD-Induced Biochemical Responses

By Kim A.H.   Kohn M.C.   Portier C.J.   Walker N.J.  

Regulatory Toxicology and Pharmacology, Vol. 36, Iss. 3, 2002-12 ,pp. : 287-296

Academic Press

Access to resources Recommend Favorite

Application of Physiologically Based Pharmacokinetic (PBPK) Modeling to Support Dose Selection: Report of an FDA Public Workshop on PBPK

By  

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 4, Iss. 4, 2015-04 ,pp. : 226-230

John Wiley & Sons Inc

Access to resources Recommend Favorite